1 / 61

Improving Stroke Prevention in Patients With Atrial Fibrillation

Improving Stroke Prevention in Patients With Atrial Fibrillation. Acknowledgement. Disclosures. Disclosures (cont.) . This presentation will not include any non-FDA approved or investigational uses of products or medical devices. Learning Objectives.

adelie
Télécharger la présentation

Improving Stroke Prevention in Patients With Atrial Fibrillation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Improving Stroke Prevention in Patients With Atrial Fibrillation

  2. Acknowledgement

  3. Disclosures

  4. Disclosures (cont.) • This presentation will not include any non-FDA approved or investigational uses of products or medical devices.

  5. Learning Objectives

  6. Atrial Fibrillation (AF): Incidence and Consequences

  7. Projected Number of Persons With AF in the US: 2000 to 2050

  8. AF and Stroke

  9. Greater Risk of Death and Recurrence With AF Strokes

  10. Disability vs Age Group in Those With Acute Ischemic Stroke (AIS) vs AF-AIS

  11. Anticoagulation: Assessing Benefits and Risks

  12. Question

  13. Case 1

  14. CHADS2 Index: A Validated Classification Scheme/Tool for Stroke Risk

  15. Weakness of CHADS2

  16. The CHA2DS2-VASc Index

  17. CHA2DS2-VASc vs CHADS2: Which to Use?

  18. Case 2

  19. ACC/AHA/ESC Guidelines

  20. Risk Stratification and Anticoagulation

  21. Underuse of Anticoagulants in AF

  22. Barriers to Anticoagulant Use

  23. Barriers to Anticoagulation?

  24. Bleeding Risk

  25. Bleeding Risk: The Reality

  26. Anticoagulation in Patients at Risk of Falls: “Physicians’ Fears Are Often Unfounded”

  27. Assessing Bleeding Risk: HAS-BLED

  28. Reducing Bleeding Risk

  29. Anticoagulation Decision Support Worksheet

  30. Anticoagulation Decision Support Worksheet (cont.)

  31. The Patient: Decision Making and Education

  32. Patient Preferences

  33. Patient vs Physician Perspectives on Anticoagulation

  34. Explaining Risk to Patients: Numerous Tools Available

  35. Patient Knowledge About Warfarin

  36. Patient Adherence to Warfarin

  37. Risk Factors for Warfarin Nonadherence

  38. Improving Patient Adherence to Anticoagulants

  39. Which Antithrombotic Therapy?

  40. Generic/Trade Name Guide for Drugs Mentioned in Presentation

  41. Features of Available Anticoagulants

  42. Warfarin and Novel Anticoagulant Mechanisms of Action

  43. Choosing an Anticoagulant

  44. Question Check

  45. Clopidogrel and/or Aspirin?

  46. ACC/AHA/ESC Guidelines: Warfarin vs Aspirin

  47. Warfarin: The Gold Standard

  48. Currently Available Oral Anticoagulants

  49. Clinical Trial Data

More Related